Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Respiratory Tract Diseases × camrelizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 5 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Nasopharyngeal Carcinoma 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Biliary Tract Carcinoma 1

Interventions

Carboplatin 3 pembrolizumab 2 durvalumab 2 Pemetrexed 2 Cisplatin 2 taletrectinib 1 sotorasib 1 selpercatinib 1 pralsetinib 1 ceralasertib 1 Radiosurgery 1 Paclitaxel 1 Gemcitabine 1 Bevacizumab 1 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡